A
AORT
Artivion, Inc.
27.20
+0.82+3.11%After Hours: 27.50 +0.30 +1.10%17:06 08/26 EDT
OPEN/PREV CLOSE26.18/26.38
TODAY RANGE26.02-27.42
VOL609.01K
MARKET CAP1.33B
52 WEEK RANGE19.16-48.25
AVG VOL (3M)748.27K
% TURNOVER1.25%
TURNOVER--
P/E (TTM)-397.0803
% RANGE5.29%
EPS(TTM)-0.0685
P/E(FORWARD)-100.7407
P/B2.972
BVPS9.15
DIVIDEND--
P/S2.949
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.21B
SHARES OUTSTANDING48.76M
NEXT EARNINGS11/04-11/09
FREE FLOAT44.60M
LOT SIZE1
EX-DATE12/09/2015
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Have Artivion Insiders Been Selling Stock?
TipRanks·5d ago
Artivion CEO Makes Bold Move With Major Insider Stock Sale
Simply Wall St·6d ago
Does Revenue Growth Amid New Losses Reshape The Bull Case For Artivion (AORT)?
TipRanks·08/19 00:14
Artivion Earnings Call: Growth Drivers vs. Debt Load
Dow Jones·08/18 13:47
Artivion Is Maintained at Buy by Canaccord Genuity
Dow Jones·08/18 13:47
Artivion Price Target Raised to $40.00/Share From $39.00 by Canaccord Genuity
Benzinga·08/18 13:37
Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40
TipRanks·08/18 11:00
Artivion price target raised to $40 from $39 at Canaccord
TipRanks·08/18 02:02
Artivion Executives Quietly Cash In With Fresh Insider Stock Moves
TipRanks·08/13 11:25
Canaccord Genuity Sticks to Its Buy Rating for Artivion (AORT)
Simply Wall St·08/12 19:28
Artivion (AORT) Is Up 5.5% After FDA AMDS Approval And Reaffirmed 2026 Revenue Guidance - What's Changed
Simply Wall St·08/11 02:37
Artivion (AORT) Revenue Rose As Losses Emerged, Is It Still 37% Below Fair Value?
Seeking Alpha·08/09 19:05
Alger Dynamic Opportunities Fund Q2 2026 Portfolio Update
Simply Wall St·08/08 03:36
Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses?
TipRanks·08/07 12:37
Oppenheimer Sticks to Their Buy Rating for Artivion (AORT)
Same Industry
Name/Symbol
Change%
Price